This paper is in the following e-collection/theme issue:

Systematic Review Protocols (268) Gastroenterology and Hepatology (68) Pediatrics (201) Pharmacology and Pharmaceutics (66) Pharmacovigilance (134)

Published on in Vol 11, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/20168, first published .
Nonalcoholic Fatty Liver Disease in Children and Adolescents Taking Atypical Antipsychotic Medications: Protocol for a Systematic Review and Meta-analysis

Nonalcoholic Fatty Liver Disease in Children and Adolescents Taking Atypical Antipsychotic Medications: Protocol for a Systematic Review and Meta-analysis

Nonalcoholic Fatty Liver Disease in Children and Adolescents Taking Atypical Antipsychotic Medications: Protocol for a Systematic Review and Meta-analysis

Authors of this article:

Reem Hatem1 Author Orcid Image ;   Faisal A Nawaz1 Author Orcid Image ;   Ghadah A Al-Sharif1 Author Orcid Image ;   Mohammad Almoosa1 Author Orcid Image ;   Wid Kattan2 Author Orcid Image ;   Christos Tzivinikos3 Author Orcid Image ;   E Lila Amirali4 Author Orcid Image ;   Ammar Albanna1, 3 Author Orcid Image
Article Authors Cited by (1) Tweetations (9) Metrics

Journals

  1. Gangopadhyay A, Ibrahim R, Theberge K, May M, Houseknecht K. Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines. Frontiers in Neuroscience 2022;16 View